Search Results

NCCN: Continuing Education Accreditation Statement This activity has been designated to meet the educational needs of physicians and nurses involved in the management of patients with cancer. There is no fee for this article. No commercial

The Veterans Health Administration (VHA) is the largest provider of cancer care in the United States. With approximately 5.5 million patients receiving care under the auspices of 153 medical centers in 2008, the VHA has the largest fully

Pulmonary embolism (PE) is a common cause of death in patients with cancer. 1 In recent years, the extensive use of scheduled CT for tumor assessment has led to increasing diagnoses of incidental PE in this population. Thus, the current clinical

Background Substance use disorders (SUDs) among cancer survivors are a modifiable prognostic factor associated with poor cancer prognosis 1 and higher health care use and costs. 2 For example, previous research on Medicare patients with

“The additional refinements in the 2019 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer on what constitutes a family history of prostate cancer will help practitioners know what to inquire about,” said James L

Testicular cancer (TC) is the most common cancer among men aged 18 to 39 years, 1 with a worldwide doubling in incidence over the past few decades. 2 In contrast to the poor survival associated with many young adult cancers, the 5- and 10-year

P atients with clinically localized prostate cancer face a wide array of management options. Treatment may include definitive local therapy. Although prostate cancer is the second leading cause of cancer mortality, with approximately 3% of all men

Almost one-third of men who undergo local treatment for prostate cancer will experience relapse and most will receive androgen-deprivation therapy. Most treated patients will eventually become resistant, however, and will develop metastatic

C olorectal cancer is less common in the Middle East and South Asia region than in the United States ( Table 1 ). However, it is among the 10 most common cancer types in all the countries. 1 The age-standardized incidence rate is below 10 per 100

NCCN: Continuing Education Accreditation Statement This activity has been designated to meet the educational needs of physicians and nurses involved in the management of patients with cancer. There is no fee for this article. No commercial